Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2009
10/14/2009CN100548350C Traditional Chinese medicine for treating thromboangitis obliterans
10/14/2009CN100548331C Compound cape-jasmine salted-fermented beans total extract and its preparation and use
10/14/2009CN100548319C Bluish dogbane extract preparing method, and its medicinal preparation and use
10/14/2009CN100548318C Water fennel total phenolic acid preparing process, and medicinal preparation using same as active component and use
10/14/2009CN100548316C Lunar caustic composition and preparing method and use thereof
10/14/2009CN100548307C Medicine for treating cardiocerebral vascular diseases
10/14/2009CN100548303C Combination product comprising melagatran and dexamethasone
10/14/2009CN100548302C Female hormone-containing patch
10/14/2009CN100548300C Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias
10/14/2009CN100548297C Slow release drop pills comprising toraesmide active ingredient and method for preparing same
10/14/2009CN100548293C Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure
10/14/2009CN100548291C MCH antagonists for the treatment of obesity
10/13/2009US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009US7601817 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis
10/13/2009US7601753 Pyrrolidine melanocortin-specific compounds
10/13/2009US7601730 Carboxylic acid derivatives, their preparation and use
10/13/2009US7601717 Pterin analogs
10/13/2009US7601712 Such as (1)-2-(4-chloro-3-((2-chloro-4-(((2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-ly)methoxy)benzoyl)amino)phenyl)-2-methylpropanoic acid; prostaglandin receptor agonists
10/13/2009US7601534 Maintaining a non-differentiated state of human stem cells, while allowing cell division of said human stem cells
10/13/2009US7601353 Peptide-based passive immunization therapy for treatment of atherosclerosis
10/13/2009US7601344 Von Hippel-Lindau (VHL) gene in cancer cells which express neuropeptide Y, neurofilament, and microtubule associated protein 2; plasmids; Parkinson's disease, amyotrophic lateral sclerosis, Huntington's chorea, Alzheimer's disease, brain infarction, spinal cord injury, brain contusion or malignant tumor
10/13/2009US7601157 Devices and methods for the restoration of a spinal disc
10/13/2009CA2521846C Reverse-turn mimetics and method relating thereto
10/13/2009CA2472373C Combination of paclitaxel and a polymer
10/13/2009CA2455298C Condensed polycyclic compounds
10/13/2009CA2455246C Drug preparation comprising .alpha.-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ace) and its use for the treatment of neurodegenerative diseases
10/13/2009CA2454022C Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis
10/13/2009CA2429844C Mch antagonists and their use in the treatment of obesity
10/13/2009CA2386974C Benzodiazepine derivatives for use in acute or chronic neurological disorders
10/13/2009CA2384037C Pyrazolo[4,3-d]pyrimidines
10/13/2009CA2379666C Agent for preventing recurrence of cerebrovascular disorder and agent for ameliorating troubles following cerebrovascular disorder and inhibiting progress thereof
10/13/2009CA2370388C Crystalline forms of the sodium salt of 5-chloro-2-methoxy-n-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonylphenyl)ethyl)benzamide
10/13/2009CA2341678C Potassium channel inhibitors and method
10/13/2009CA2334775C Benzo(b)thiepine-1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
10/13/2009CA2322311C Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
10/13/2009CA2291218C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels
10/13/2009CA2222650C Tnf-.alpha. converting enzyme
10/08/2009WO2009124300A2 Solid state forms of a pharmaceutical
10/08/2009WO2009124259A1 Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors
10/08/2009WO2009124184A2 Methods of activating rnase l
10/08/2009WO2009124103A2 Combination therapies comprising par1 antagonists with par4 antagonists
10/08/2009WO2009123986A1 Apoptosis signal-regulating kinase 1 inhibitors
10/08/2009WO2009123742A1 Use of ribose in first response to acute myocardial infarction
10/08/2009WO2009123573A1 Anticoagulants derived from naja nigricollis snake venom
10/08/2009WO2009123454A1 Compositions and method for reducing scar formation in wound healing
10/08/2009WO2009123316A1 Heterocyclic derivative and use thereof
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009WO2009123221A1 Pyrimidine derivative having cell-protecting activity and use thereof
10/08/2009WO2009123211A1 Agents for maturing, normalizing or stabilizing blood vessels and wrinkle-preventing and improving agents
10/08/2009WO2009123210A1 Preventive and/or remedy for vascular diseases
10/08/2009WO2009123164A1 Heterocyclic derivative having inhibitory activity on endothelial lipase
10/08/2009WO2009122710A1 Medical composition
10/08/2009WO2009122707A1 1,3-dihydroisobenzofuran derivative
10/08/2009WO2009122183A1 New combination for use in the treatment of inflammatory disorders
10/08/2009WO2009122182A1 New combination for use in the treatment of inflammatory disorders
10/08/2009WO2009122181A1 New combination for use in the treatment of inflammatory disorders
10/08/2009WO2009122148A1 Fused thiophene and thiazole derivatives as pi3k kinase inhibitors
10/08/2009WO2009121939A2 C-aryl glycoside compounds for the treatment of diabetes and obesity
10/08/2009WO2009121812A1 Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists
10/08/2009WO2009121687A1 L-citrulline for treating endothelial dysfunction and erectile dysfunction
10/08/2009WO2009121223A2 Use of prourokinase and variants thereof in facilitated percutaneous coronary intervention in patients with acute myocardial infarction
10/08/2009WO2009121176A1 Insulin-induced gene (insig) peptide compositions and methods for cytoprotection
10/08/2009WO2009100435A3 Sclerotherapy for varicose veins
10/08/2009WO2009093210A3 SUBSTITUTED CYCLOALCANO[e AND d] PYRAZOLO [1,5-a]PYRIMIDINES/ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS AND METHODS FOR PRODUCTION AND THE USE THEREOF
10/08/2009WO2009093209A3 2-ALKYLAMINO-3-ARYLSULFONYL-CYCLOALCANO [e OR d] PYRAZOLO [1,5-A]PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF
10/08/2009WO2009077874A3 A pharmaceutical composition for treating esophageal cancer
10/08/2009WO2009040045A3 Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents
10/08/2009WO2009033758A3 Use of the peptide phpfhffvyk as therapeutic agent
10/08/2009WO2008118552A9 Use of ranolazine for the treatment of cardiovascular diseases
10/08/2009WO2008112022A8 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
10/08/2009WO2008101724A8 Use of riboflavin in the treatment of hypertension
10/08/2009WO2008080844A9 Azaspiro derivatives
10/08/2009US20090255004 G-Protein Coupled Receptor and Uses Therefor
10/08/2009US20090253807 Aqueous suspension preparations
10/08/2009US20090253801 Novel Antiarrhythmic Drug Formulations
10/08/2009US20090253796 Method for treating vascular disease
10/08/2009US20090253789 Preventive/Remedy for Arteriosclerotic Disease and Method of Evaluating Therapeutic Procedure
10/08/2009US20090253781 Therapeutic compositions
10/08/2009US20090253767 Aminoindazolylurea derivatives
10/08/2009US20090253766 Thiophene derivatives as factor xia inhibitors
10/08/2009US20090253764 Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them
10/08/2009US20090253753 Therapeutic Use of Acylaminothiazole Derivatives
10/08/2009US20090253738 TRIAZOLOPYRIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/08/2009US20090253703 Organic compounds
10/08/2009US20090253701 such as (2S,4S,5S,7S)-5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (2-phenoxy-ethyl)-amide, having renin-inhibiting properties, used for the treatment of hypertension, cardiovascular, vision, neurodegenerative, kidney and liver disorders
10/08/2009US20090253699 Compounds for Nonsense Suppression, and Methods for Their Use
10/08/2009US20090253693 2H-BENZO[b][1,4]OXAZIN-3(4H)-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/08/2009US20090253690 N-[3-(1-piperidinyl)propoxy]-pyridin-1-oxide-3-carboxamidine; cardiovascular disorders; treating dysfunction of endothelial cells
10/08/2009US20090253689 Organic Compounds
10/08/2009US20090253687 Fused Heterocyclic Compounds and Their Use as Mineralocorticoid Receptor Ligands
10/08/2009US20090253683 7-membered ring compound and method of production and pharmaceutical application thereof
10/08/2009US20090253675 Pharmaceutical formulation
10/08/2009US20090253665 Method of treatment of disease using an adenosine a1 receptor antagonist and an aldosterone inhibitor
10/08/2009US20090253662 Genetic risk assessment in heart failure: impact of genetic variation of aldosterone synthase promoter polymorphism
10/08/2009US20090253649 Agents Containing Folic Acid, Vitamin B6 and Vitamin B12, and the Use Thereof
10/08/2009US20090253646 Pan-selectin inhibitor with enhanced pharmacokinetic activity
10/08/2009US20090253625 GLP-1, exendin-4, peptide analogs and uses thereof
10/08/2009US20090253175 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments
10/08/2009US20090252758 Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
10/08/2009US20090252752 Kdr peptides and vaccines comprising the same
1 ... 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 ... 1595